Average article processing time (30-45 days)
Less than 5 volumes 30 days
8 - 9 volumes 40 days
10 and more volumes 45 days
Reach us
+44 7460731551
Abstract
BRCA and Pancreatic Cancer
Muhammad Wasif Saif, Gregory T Brennan, Valerie Relias
Germline mutations in BRCA genes have been associated with pancreatic cancer. Laboratory and clinical data suggest thatpatients with BRCA mutations may be more responsive to therapy consisting of conventional chemotherapy with apoly(ADP-ribose) polymerase inhibitor (PARPi). The most recent data from the 2013 American Society of Clinical Oncology(ASCO) Annual Meeting will be reviewed (Abstracts #11024 and #TPS4144).
